• Latest Posts

Santhera and ReveraGen announce first patient with Becker muscular dystrophy dosed in FDA-funded pilot study

Sarepta looks for quick approval for Duchenne muscular dystrophy gene therapy treatment

CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M


Muscular Dystrophy Drug Fails in Phase 2 Trial

This Small Molecule Protects the Muscles of Patients With Duchenne Muscular Dystrophy

Cutting Through the BS in Biopharma: How To Spot Hype

Swiss Scientists Have Designed New Proteins to Treat Muscular Dystrophy

French Nonprofit Partners with Big American Name to Advance a Gene Therapy for Muscular Dystrophy

More News! 30 May 2017

FDA Fast Tracks Muscular Dystrophy Drug backed by Woodford